Hear from Paul Biondi, President of Pioneering Medicines and Executive Partner, Ä¢¹½ÊÓƵAPP, and Uli Stilz, Vice President, Novo Nordisk Bio Innovation Hub, on a new partnership bringing together Flagship’s ecosystem of first-in-category bioplatforms with the disease expertise of Novo Nordisk, to jointly create a portfolio of transformational medicines.
More from:
Human Health

Pioneering Partnerships: Advancing a Portfolio of Novel Medicines and Vaccines with GSK

Pioneering Partnerships: Accelerating our Collaboration with Pfizer

Unlocking Therapeutic Breakthroughs with the Power of Platform Technologies

Halting the Trajectory of Disease with Preemptive Health

AI in Action
